


| Revenue | Over $500 million See Exact Annual Revenue |
|---|---|
| Employees | Over 1,000Exact Company Size |
| Primary Industry | 325411 Medicinal & Botanical Manufacturing |
| Additional NAICS Codes | 5416 Management, Scientific & Technical Consulting Services |
| Address | 126 East Lincoln Avenue P.o. Box 2000 Rahway, NJ 07065 |
| Merck | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | Over $500 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Merck P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| DIVITAZ Pharmaceutical preparations for the treatment of diabetes, respiratory, sleep disorders, cardiovascular diseases and disorders, diseases and disorders of the central nervous system, cancer, musculoskeletal disorders, osteoporosis, anti-infective preparations, anti-viral preparations, immunological preparations, analgesic preparations, ophthalmic preparations, dermatological preparations and vaccine preparations | 10/09/2009 |
| DYBACRET Pharmaceutical preparations for the treatment of diabetes, respiratory, sleep disorders, cardiovascular diseases and disorders, diseases and disorders of the central nervous system, cancer, musculoskeletal disorders, osteoporosis, anti-infective preparations, anti-viral preparations, immunological preparations, analgesic preparations, ophthalmic preparations, dermatological preparations and vaccine preparations | 10/09/2009 |
| GLUTUVIA Pharmaceutical preparations for the treatment of diabetes, respiratory, sleep disorders, cardiovascular diseases and disorders, diseases and disorders of the central nervous system, cancer, musculoskeletal disorders, osteoporosis, anti-infective preparations, anti-viral preparations, immunological preparations, analgesic preparations, ophthalmic preparations, dermatological preparations and vaccine preparations | 10/09/2009 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| XYMOGEN | Orlando, FL | 100 |
| AVANTI NUTRITIONAL LABORATORIES | Miami Lakes, FL | 37 |
| NUTRITION FORMULATORS | Miramar, FL | 36 |
| RTPR | Cabot, AR | 33 |
| INTEGRATED BOTANICS | Fort Worth, TX | 29 |
| COSMAX NBT USA | Garland, TX | 29 |
| CJB INDUSTRIES | Valdosta, GA | 28 |
| ALTERNATIVE LABORATORIES | Naples, FL | 28 |
| S&B PHARMA | Azusa, CA | 28 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| MERCK SHARP & DOHME | Rahway, NJ | 100 |
| MERCK | Rahway, NJ | 95 |
| ZOETIS | Parsippany, NJ | 26 |
| TEVA PHARMACEUTICALS USA | Parsippany, NJ | 18 |
| GLAXOSMITHKLINE CONSUMER HEALTHCARE | Warren, NJ | 10 |
| CAMBREX | East Rutherford, NJ | 5 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| MERCK SHARP & DOHME | Rahway, NJ | 100 |
| ACCELERON PHARMA | Rahway, NJ | 0 |
| PANDION THERAPEUTICS | Rahway, NJ | 0 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |